| N* | uOR | 95% CI | p-value | |
---|---|---|---|---|---|
Accelerated treatment group | 595 | 1.61 | 1.16 | 2.24 | 0.01 |
City | 595 | Â | Â | Â | Â |
  Chicago |  | Reference |  |  |  |
  Hartford |  | 0.75 | 0.46 | 1.22 | 0.25 |
  Bridgeport | 0.48 | 0.24 | 0.93 | 0.03 | |
Race | 588 | Â | Â | Â | Â |
  Non-Hispanic Black/African American |  | Reference |  |  |  |
  White |  | 0.74 | 0.49 | 1.13 | 0.15 |
  Hispanic |  | 0.63 | 0.43 | 0.94 | 0.02 |
  Excluded Native American/Alaskan Native, Other, Refused (n = 7) |  |  | |||
Women | 594 | 1.45 | 1.00 | 2.11 | 0.05 |
Age (continuous, range 18–68) | 595 | 1.05 | 1.03 | 1.07 | <.01 |
Education | 581 | Â | Â | Â | Â |
  Less Than high school | Reference |  |  |  | |
  High school or graduate equivalency degree |  | 0.94 | 0.63 | 1.39 | 0.74 |
  Some College or College graduate | 1.15 | 0.76 | 1.75 | 0.51 | |
  Excluded missing other (14) and vocation schools (11) |  |  |  | ||
Employment (Full- or part-time) | 578 | 0.66 | 0.44 | 1.01 | 0.05 |
Average monthly income | Â | Â | Â | Â | |
  $0-300 |  | Reference |  |  |  |
  $301-556 |  | 0.87 | 0.52 | 1.45 | 0.58 |
  $557-1,000 | 1.10 | 0.70 | 1.73 | 0.68 | |
  $1,001-9,000 | 0.76 | 0.47 | 1.23 | 0.26 | |
Not homeless | 577 | 0.93 | 0.66 | 1.31 | 0.68 |
Excluded missing (n = 14), and don’t know (n = 4) |  |  |  |  | |
Pay for housing | 582 | 1.43 | 1.03 | 1.99 | 0.04 |
Self-reported health status (Likert 1 = excellent, 5 = poor) | 578 | 1.21 | 1.02 | 1.42 | 0.03 |
Excluded missing (13) and don’t know (4) |  |  |  |  |  |
Told by health care worker HCV pos | 576 | 0.97 | 0.59 | 1.60 | 0.90 |
Excluded missing (15) and don’t know/unsure (4) |  |  |  |  |  |
Doctors visit during past year | 582 | 1.06 | 0.74 | 1.51 | 0.80 |
Customer of local syringe exchange | 539 | 0.98 | 0.64 | 1.49 | 0.91 |
Main source of syringes, prior 30Â days | 558 | Â | Â | Â | Â |
  SEP direct |  | Reference |  |  |  |
  Pharmacy |  | 0.45 | 0.19 | 1.05 | 0.06 |
  SEP customer |  | 0.37 | 0.22 | 0.64 | <0.01 |
  Diabetic, someone else, at place you shoot |  | 0.79 | 0.47 | 1.34 | 0.38 |
Excluded missing (37) | Â | Â | Â | Â | Â |
Most syringes from this exchange, past 3Â months | 462 | 1.59 | 1.07 | 2.37 | 0.02 |
EVER referred by SEP to healthcare/drug tx/social service | 575 | 1.29 | 0.28 | 2.00 | 0.26 |
Excluded missing (17) don’t know (3) |  |  |  |  |  |
Average # of shots from a syringe (range 1–75) | 557 | 0.98 | 0.93 | 1.02 | 0.31 |
Total injections, prior 30 days (range 1–540) | 521 | 1.00 | 0.99 | 1.00 | 0.84 |
Excluded does not apply (n = 25) |  |  |  |  |  |
Used a needle someone else had used at least, prior 30Â days | 553 | 1.73 | 0.90 | 3.33 | 0.10 |
Someone paid you w/ drugs or money for sex | 580 | 1.21 | 0.81 | 1.80 | 0.36 |
You paid someone with drugs or money for sex | 575 | 0.83 | 0.55 | 1.25 | 0.38 |
Language of interview | 582 | Â | Â | Â | Â |
  English |  | Reference |  |  |  |
  Spanish |  | 0.57 | 0.30 | 1.10 | 0.09 |
Language spoken most often | 578 | Â | Â | Â | Â |
  English |  | Reference |  |  |  |
  Spanish |  | 0.76 | 0.45 | 1.27 | 0.30 |
  Excluded missing and other (n = 3) |  |  |  |  |  |
Hepatitis Knowledge | 585 | 2.78 | 0.45 | 17.10 | 0.27 |
Vulnerability | 581 | 1.01 | 0.85 | 1.19 | 0.94 |
Severity | 581 | 1.10 | 0.93 | 1.30 | 0.25 |
Response efficacy | 580 | 1.01 | 0.85 | 1.19 | 0.94 |
Self-efficacy | 581 | 0.93 | 0.79 | 1.10 | 0.39 |
Social outcome expectancy | 580 | 1.04 | 0.88 | 1.23 | 0.64 |
Social outcome value | 581 | 1.05 | 0.89 | 1.24 | 0.57 |